U.S. Code of Federal Regulations
Regulations most recently checked for updates: Aug 28, 2025
Searching within:
All TitlesTitle 21Chapter IPart 316Subpart A - Subpart A—General Provisions
Exit search mode at current location
Exit search mode at current location
All correspondence and requests for FDA action under the provisions of this rule should be addressed as follows: Office of Orphan Products Development, Food and Drug Administration, Bldg. 32, Rm. 5271, 10903 New Hampshire Ave., Silver Spring, MD 20993.
